← FDA DRUG APPROVALS

FDA NDA · NDA018555

YUTOPAR

Sponsor: ASTRAZENECA

APPLICATION
NDA018555
TYPE
NDA
ORIGINAL APPROVAL
1980-12-12
LATEST ACTION
1996-03-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

YUTOPARDiscontinued
RITODRINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

1996-03-27Labeling · Supplement 5AP
1996-03-27Labeling · Supplement 14 · standardAP
1996-03-27Labeling · Supplement 15 · standardAP
1996-03-27Labeling · Supplement 2AP
1996-03-27Labeling · Supplement 7AP
1987-06-23Labeling · Supplement 13AP
1986-11-19Labeling · Supplement 12AP
1986-04-17Labeling · Supplement 11AP
1980-12-12Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →